Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 235.58MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
Sector
Industry
History
$ 14.26Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information
Ticker
TBPHCompany Name
THERAVANCE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTHERAVANCE BIOPHARMA INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TBPH - CF - Chg. Cash Historical data
| Date | Net Cash Flow - Change in Cash & Cash Equivalents |
|---|---|
| 6/30/2025 | $ 235.58M |
| 3/31/2025 | $ 56.78M |
| 12/31/2024 | $ -1.75M |
| 9/30/2024 | $ -48.31M |
| 6/30/2024 | $ -59.25M |
| 3/31/2024 | $ -133.83M |
| 12/31/2023 | $ -258.63M |
| 9/30/2023 | $ -346.85M |
| 6/30/2023 | $ 18.3M |
| 3/31/2023 | $ 93.3M |
Key Performance Insights, Last 5 Years
- THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -16.62M.
- Over the past 5 years, THERAVANCE BIOPHARMA INC's average CF - Chg. Cash has been $ -7.59M.
- The median CF - Chg. Cash for THERAVANCE BIOPHARMA INC during this period was $ 3.37M
- THERAVANCE BIOPHARMA INC reached its highest CF - Chg. Cash over the past 5 years at $ 297.12M.
- The lowest CF - Chg. Cash recorded by THERAVANCE BIOPHARMA INC in the same timeframe $ -346.85M
THERAVANCE BIOPHARMA INC's CF - Chg. Cash vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CF - Chg. Cash Benchmarks
Similar metrics to CF - Chg. Cash:
- Net Cash Flow - Exchange Rate Changes on Cash - [Cash Flow Statement] Refers to the effect of exchange rate changes on cash and cash equivalent balances held in foreign currencies.
- Net Cash Flow - Operations - [Cash Flow Statement] Cash flow from operations represents the amount of cash inflow (outflow) that a company generates (consumes) from operating activities. Similar to Net Income [NetIncCmn] but harder to manipulate and ignoring effects of non-cash charges like depreciation.
- Net Cash Flow - Investing - [Cash Flow Statement] The amount of cash inflow (outflow) from investing activities. Investing actives include disposal (expenditure) of capital assets [CapEx], sale (purchase) of business [NCFBus] and of investments [NCFInv].
- Net Cash Flow - Financing - [Cash Flow Statement] The amount of cash inflow (outflow) from financing activities. Financing activities include issuance (purchase) of equity shares, issuance (repayment) of debt, and the payment of dividends.
- Free Cash Flow to Operating Cash Flow - [Calculation] The Free Cash Flow to Cash Flow from Operations ratio, describes how much of a company’s operating cash flow [NCFO] is free to be invested after capital expenditures [CapEx].
Definition of Net Cash Flow - Change in Cash & Cash Equivalents
[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]TBPH - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years
$ -346.85M
Minimum
Sep 30, 2023
$ 297.12M
Maximum
Sep 30, 2022
$ -7.59M
Average
$ 3.37M
Median
CF - Chg. Cash Benchmark AnalysisMarket
The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
| filtered constituents | 3.34K |
|---|---|
| min | $ -136.09M |
| max | $ 137.58M |
| average | $ 1.18M |
| median | $ 115.89K |
| std | $ 44.92M |